Webinars and
Presentations
Access our latest webinar and scientific presentations to hear directly from Pillar Biosciences experts and industry leaders. Stay up to date on emerging trends, innovative technologies, and our ongoing research in precision diagnostics.
Webinar: Accelerating Precision Medicine with Rapid Front-Line NGS
Pillar Biosciences – CAP Today Webinar
04.30.2026
Rapid NGS Testing in Myeloid Malignancies: Pillar Biosciences Workflow, Use Cases, and Long FLT3-ITD Detection
Pillar Biosciences – CGC 2026
08.04.2026
From Innovation to Implementation: Redefining Breast Cancer Management with Liquid Biopsy
Pillar Biosciences – AMP Europe 2026
06.15.2026
Webinar: Accelerating Precision Medicine with Rapid Front-Line NGS
Pillar Biosciences – CAP Today Webinar
04.30.2026
Rapid Detection of Actionable Biomarkers in Liquid Biopsy from Non-Small Cell Lung Cancer and Breast Cancer Using Targeted NGS-Based Assays
Pillar Biosciences – AMP 2025
11.12.2025
Laboratory Validation of Pillar’s oncoReveal Myeloid Panel on the Illumina MiSeq i100 to Deliver Rapid Front-Line NGS for Heme Malignancies
Pillar Biosciences – AMP 2025
11.12.2025
Accelerating Precision Medicine with Rapid Front-Line NGS
Pillar Biosciences – AMP 2025
11.12.2025
Webinar: Improving Access to NGS-Based Liquid Biopsy Testing for Advanced Cancers
GenomeWeb | Precision Medicine
09.29.2025
Webinar: Optimizing Your Lab’s Precision Medicine Strategy Through Rapid, Front-Line NGS
Pillar Biosciences – Dark Daily
04.16.2025
The Simple Verification in a Molecular Pathology Lab of the FDA Approved oncoReveal CDx Pan-Cancer Solid Tumor IVD Assay
Pillar Biosciences – AMP 2024
11.20.2024
Pillar Biosciences – AMP 2024
11.20.2024
Pillar Biosciences – AMP 2024
11.20.2024
Webinar: Accelerating Access to Liquid Biopsy Testing with Kitted NGS Solutions
GenomeWeb | Precision Medicine
08.27.2024
Webinar: Targeted NGS as a Front-Line Strategy to Accelerate the Delivery of Precision Medicine for Solid and Heme Tumors
GenomeWeb | Precision Medicine
12.05.2024
Webinar: Streamlining the Clinical Laboratory Workflow of Myeloproliferative Neoplasms with Next-Generation Sequencing
GenomeWeb | Precision Medicine
06.11.2024
Localized (RUO) NGS Methylation Testing to Help Inform BioPharma Clinical Trials and Improve Oncology Research
Pillar Biosciences – AMP 2023
10.23.2023
Pillar Biosciences – AMP 2023
2023
Webinar: Looking Deeper into HRD to Inform PARP Inhibitor Therapy: Building the Case for NGS Methylation Testing
GenomeWeb | Precision Medicine
10.10.2023
Evaluation of oncoReveal Dx Lung and Colon Cancer Assay (oRDx-LCCA) For Tumor Profiling Using Multiple Tumor Types
Pillar Biosciences – AMP 2022
2022
PARPi Response Prediction with Pillar Biosciences’ oncoReveal Geentic and Epigenetic Alteration Panels
Pillar Biosciences
2021
Pillar Biosciences
2020
Pillar Biosciences
2020
Pillar Biosciences
2019
Want to be the first to know about new
and exciting news at Pillar Biosciences?
Sign up for our mailing list here